Takeda Pharmaceutical's Income from Continuing Operations fell 1937.44% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $14.0 billion, marking a year-over-year increase of 3346.36%. This contributed to the annual value of $709.9 million for FY2025, which is 2899.72% down from last year.
Takeda Pharmaceutical's Income from Continuing Operations amounted to $1.1 billion in Q4 2025, which was down 1937.44% from $7.5 billion recorded in Q3 2025.
Over the past 5 years, Takeda Pharmaceutical's Income from Continuing Operations peaked at $7.5 billion during Q3 2025, and registered a low of $487.8 million during Q3 2022.
In the last 5 years, Takeda Pharmaceutical's Income from Continuing Operations had a median value of $1.4 billion in 2024 and averaged $2.1 billion.
Per our database at Business Quant, Takeda Pharmaceutical's Income from Continuing Operations skyrocketed by 64822.38% in 2021 and then tumbled by 7115.93% in 2022.
Over the past 5 years, Takeda Pharmaceutical's Income from Continuing Operations (Quarter) stood at $761.5 million in 2021, then fell by 11.55% to $673.6 million in 2022, then surged by 161.65% to $1.8 billion in 2023, then dropped by 25.02% to $1.3 billion in 2024, then dropped by 19.37% to $1.1 billion in 2025.
Its last three reported values are $1.1 billion in Q4 2025, $7.5 billion for Q3 2025, and $2.6 billion during Q2 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value